Research Article
Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension
Table 2
Anthropometric and biochemical measures.
| | Characteristics | Baseline | 6 months after RDN | value |
| | Men/women | 6/2 | | | | Age (years) | 62.5 ± 2.55 | | | | BMI (kg/m2) | 28.9 (26.6; 34.0) | 29.9 (26.4; 34.2) | 0.94 | | Fasting plasma glucose (mmol/l) | 6.31 ± 0.35 | 6.14 ± 0.31 | 0.29 | | HbA1c (mmol/mol) | 37.0 (35.0; 39.0) | 37.5 (36.0; 40.5) | 0.58 | | P-sodium (mmol/l) | 142.4 ± 0.68 | 141.9 ± 0.74 | 0.52 | | P-potassium (mmol/l) | 3.45 (3.15; 3.60) | 3.55 (3.40; 3.65) | 0.06 | | P-total cholesterol (mmol/l) | 5.26 ± 0.41 | 5.25 ± 0.36 | 0.91 | | P-LDL cholesterol (mmol/l) | 3.18 ± 0.34 | 3.19 ± 0.31 | 0.94 | | P-HDL cholesterol (mmol/l) | 1.33 ± 0.11 | 1.34 ± 0.14 | 0.74 | | P-triglycerides (mmol/l) | 1.45 (1.05; 2.25) | 1.35 (1.10; 1.95) | 0.94 | | P-TSH (×10−3 ie/l) | 1.95 (1.36; 2.81) | 1.80 (1.40; 2.73) | 0.38 | | P-ALAT (I/U) | 23.50 ± 3.82 | 23.63 ± 4.83 | 0.93 | | P-creatinine (μmol/l) | 86.88 ± 7.52 | 84.38 ± 7.62 | 0.53 | | eGFR (ml/min) | 72.38 ± 4.80 | 76.00 ± 4.67 | 0.31 | | B-leucocytes (×109/l) | 5.36 ± 0.39 | 5.49 ± 0.46 | 0.76 | | B-thrombocytes (×109/l) | 194.4 ± 15.9 | 188.1 ± 14.6 | 0.40 | | B-hemoglobin (mmol/l) | 9.04 ± 0.26 | 8.93 ± 0.24 | 0.41 |
|
|
All data are presented as means with SE or median (range).
|
